OSU Partners With Seattle Institute to Form World’s First Organization to Accelerate Advances in Personalized Medicine

The Ohio State University Medical Center has joined forces with Seattle’s Institute for Systems Biology (ISB) to establish a new consortium dedicated to advancing the field of personalized medicine.  Named the P4 Medicine Institute (P4MI), it becomes the world’s only organization dedicated to accelerating the emergence and adoption of healthcare that is predictive, preventive, personalized and participatory (the 4 p’s).
“Partnerships like this reinforce The Ohio State University Medical Center’s commitment to improve lives through personalized health care,” says Dr. Steven G. Gabbe, CEO of the Medical Center.

P4 Medicine utilizes advances in genomics and molecular diagnostics discoveries to provide predictive information that is necessary to tailor disease management approaches for each individual. Therapeutics and health management tools will be developed to help prevent disease instead of merely treating the symptoms. Medicine of the future will also be participatory. Patients will have access to a single portal that will electronically store their medical records and genetic profiles and tools that will analyze these data to guide them to precise strategies to promote wellness.

“We are very excited for this unique opportunity to partner with the Institute for Systems Biology to launch this new P4 Medicine Institute, which will help us further move toward our goal of transforming disease-based care of today to wellness-based care of the future,” says Dr. Clay Marsh, executive director of Ohio State’s Center for Personalized Health Care.

For more information, see the release from OSU Medical Center